down arrow

Aarti Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE0LRU01027
  • NSEID: AARTIPHARM
  • BSEID: 543748
INR
675.60
49 (7.82%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 6.83 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationNine Monthly Results
Results Snapshot
Figures in Rs cr
Consolidate Nine Monthly Results
Dec'24
Dec'23
Dec'22
Net Sales
1,551.30
1,346.84
1,460.17
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,551.30
1,346.84
1,460.17
Raw Material Cost
701.57
656.91
787.31
Purchase of Finished goods
192.91
122.31
206.14
(Increase) / Decrease In Stocks
-45.36
-11.63
-118.69
Employee Cost
118.59
101.01
96.46
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.01
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
264.84
209.71
226.88
Total Expenditure (Excl Depreciation)
1,232.56
1,078.31
1,198.10
Operating Profit (PBDIT) excl Other Income
318.74
268.53
262.07
Other Income
11.73
2.86
1.57
Operating Profit (PBDIT)
330.47
271.39
263.64
Interest
20.31
12.54
15.12
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
310.16
258.85
248.52
Depreciation
64.09
54.11
46.59
Profit Before Tax
246.07
204.74
201.93
Tax
62.01
53.09
51.32
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
184.07
151.65
150.61
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
184.07
151.65
150.61
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
184.07
151.65
150.61
Equity Capital
45.31
45.31
45.31
Face Value
5.0
5.0
5.0
Reserves
0.00
0.00
0.00
Diluted Earnings per share
8.16
5.82
5.26
Operating Profit Margin (Excl OI)
20.55%
19.94%
17.95%
Gross Profit Margin
19.99%
19.22%
17.02%
PAT Margin
11.87%
11.26%
10.31%
Public Share Holdings (%)
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
Nine Monthly Analysis Highlights
stock-summary

Net Sales

YoY Growth in nine months ended Dec 2024 is 15.18% vs -7.76% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in nine months ended Dec 2024 is 21.38% vs 0.69% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in nine months ended Dec 2024 is 18.70% vs 2.46% in Dec 2023

stock-summary

Interest

YoY Growth in nine months ended Dec 2024 is 61.96% vs -17.06% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in nine months ended Dec 2024 has improved from Dec 2023

Compare Nine Monthly Results Of Aarti Pharma With
Markets Mojo
Figures in Rs cr
Consolidate Nine Monthly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,551.30
9,199.93
-7,648.63
-83.14%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,551.30
9,199.93
-7,648.63
-83.14%
Raw Material Cost
701.57
1,471.08
-769.51
-52.31%
Purchase of Finished goods
192.91
1,244.57
-1,051.66
-84.50%
(Increase) / Decrease In Stocks
-45.36
-93.01
47.65
51.23%
Employee Cost
118.59
1,989.92
-1,871.33
-94.04%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.01
0.00
0.01
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
264.84
2,225.77
-1,960.93
-88.10%
Total Expenditure (Excl Depreciation)
1,232.56
6,838.33
-5,605.77
-81.98%
Operating Profit (PBDIT) excl Other Income
318.74
2,361.60
-2,042.86
-86.50%
Other Income
11.73
287.35
-275.62
-95.92%
Operating Profit (PBDIT)
330.47
2,648.95
-2,318.48
-87.52%
Interest
20.31
238.94
-218.63
-91.50%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
310.16
2,410.01
-2,099.85
-87.13%
Depreciation
64.09
405.66
-341.57
-84.20%
Profit Before Tax
246.07
2,007.79
-1,761.72
-87.74%
Tax
62.01
427.80
-365.79
-85.50%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
184.07
1,576.55
-1,392.48
-88.32%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
184.07
1,576.55
-1,392.48
-88.32%
Share in Profit of Associates
0.00
9.92
-9.92
-100.00%
Minority Interest
0.00
-7.70
7.70
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
184.07
1,570.19
-1,386.12
-88.28%
Equity Capital
45.31
40.06
5.25
13.11%
Face Value
5.00
1.00
0.00
Reserves
0.00
0.00
0.00
Gross Profit Margin
19.99%
26.20%
0.00
-6.21%
PAT Margin
11.87%
17.14%
0.00
-5.27%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 1,551.30 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

YoY Growth in nine months ended Dec 2024 is 15.18% vs -7.76% in Dec 2023

Nine Monthly - Consolidate Net Profit
Consolidate Net Profit 184.07 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

YoY Growth in nine months ended Dec 2024 is 21.38% vs 0.69% in Dec 2023

Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 318.74 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

YoY Growth in nine months ended Dec 2024 is 18.70% vs 2.46% in Dec 2023

Nine Monthly - Interest
Interest 20.31 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

YoY Growth in nine months ended Dec 2024 is 61.96% vs -17.06% in Dec 2023

Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 20.55%
in Dec 2024

Figures in Rs %
stock-summary

YoY Growth in nine months ended Dec 2024 has improved from Dec 2023